25.57
+1.35%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Caris Life Sciences
From its filings with the US Securities and Exchange Commission
Caris Life Sciences is based in Irving, Texas and is incorporated in Texas. Its shares trade on Nasdaq under the ticker CAI. The SEC classifies its business as medical laboratories. In the fiscal year to 31 December 2025, it reported revenue of $812.0m and a net loss of $68.1m. At that date it held total assets of $1.13bn and shareholders' equity of $577.3m.
We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets.
We founded Caris in 2008 with the belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights could realize the potential of precision medicine for patients. We have spent the last 17 years developing and building our portfolio of comprehensive, proprietary molecular profiling solutions and generating what we believe to be one of the largest and most comprehensive multi-modal clinico-genomic datasets in oncology. As of December 31, 2025, we have performed sequencing on over 1,000,000 cases. Our platform is purpose-built to leverage the convergence of next-generation sequencing (“NGS”), artificial intelligence (“AI”) and machine learning (“ML”) technologies, and high-performance computing.
Quoted from its 10-K, filed 3 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Industrials
- Industry
- Trading Companies & Distributors
- Listed since
- 7 Feb 2007
- Employees
- 218
- Website
- capps.com ↗
- Head office
- 750 W JOHN CARPENTER FREEWAY, IRVING, TX, 75039
- Incorporated in
- TX
- Classification
- Services-Medical Laboratories
- Filer status
- <br>Emerging growth company
Leadership
Pay as last reported
- Mr. David HalbertChairman of the Board, Chief Executive Officer, Founder, since 2008$2.3m
- Dr. David SpetzlerPresident$1.2m
- Mr. Brian BrilleVice Chairman of the Board, Executive Vice President, since 2018$1.2m
- Dr. Jonathan KnowlesVice Chairman of the Board, since 2009$50,000
- Dr. George PosteVice Chairman of the Board, since 2008$162,500
- Mr. Luke PowerChief Financial Officer, Senior Vice President, Chief Accounting Officer
- Mr. J. Russel DentonSenior Vice President, General Counsel, Secretary
- Mr. Peter CastlemanLead Independent Director$77,750
- Mr. Jon HalbertDirector$50,000
- Mr. Nathan BurnsIndependent Director
- Mr. David FredricksonIndependent Director$988,000
- Mr. Joseph GilliamIndependent Director$60,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- CAI International leases intermodal shipping containers with long-term leases for stable revenue streams.
- The company operates two reportable segments: container leasing and logistics for diversified income.
- CAI International manages equipment for third-party investors in the transportation finance sector.
Weaknesses
- CAI International's fleet is primarily focused on intermodal shipping containers and railcars, limiting diversification.
- The company's logistics services are limited to domestic and international operations without specific market expansion details.
- CAI International's employees number 218, which may be insufficient for large-scale operations.
Opportunities
- CAI International can expand its container leasing services to new markets in the US transportation sector.
- The company may increase its logistics services to meet growing demand in global trade.
- CAI International could leverage its fleet management expertise to attract more third-party investors.
Threats
- CAI International faces competition from other transportation finance companies in the US market.
- The company's reliance on intermodal shipping containers could be affected by changes in global trade policies.
- Economic downturns may reduce demand for container leasing and logistics services in the transportation industry.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.